Heather Preston, Director at Karuna Therapeutics, Inc. (KRTX), bought 3,050 shares at $80.00 ($227K) on 2020-03-10, disclosed to the SEC on 2020-03-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $80.00 | 1,000 | $80K | 35.2% |
| 2 | $69.17 | 550 | $38K | 16.8% |
| 3 | $70.00 | 500 | $35K | 15.4% |
| 4 | $73.00 | 500 | $37K | 16.1% |
| 5 | $74.91 | 500 | $37K | 16.5% |
| Total | $74.43 avg | 3,050 |
| $227K |
| 100% |
| Filing → |
| AKUS | BUY | 2020-07-02 | $5.1M | — | Filing → |
| KRTX | BUY | 2020-01-10 | $56K | — | Filing → |
| KRTX | BUY | 2020-01-07 | $100K | — | Filing → |